Patents by Inventor Steven Hill

Steven Hill has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20050227029
    Abstract: A commercially viable paper wrapped foam cup comprising a taper portion that prevents the shrinkage-induced curling from interfering with the un-nesting of nested paper wrapped foam cups. The paper wrapped cup further comprises a fillet for strengthening the cup foot to retard shrinkage-induced curling of the foot. The paper wrapper has abutting to overlapping opposing ends to completely hide the foam cup to enhance the visual appearance of the cup. The overlapping portions of the paper wrapper are not bonded to each other to prevent wrinkling of the paper wrapper as the cup shrinks. A machine and corresponding method provide for automatically supplying foam cups and paper wrappers, wrapping the paper wrapped cup, and stacking the wrapped cups.
    Type: Application
    Filed: April 7, 2005
    Publication date: October 13, 2005
    Applicant: DART CONTAINER CORPORATION
    Inventors: Robert Dart, Roger Payne, Steven Hills, Steven Makela, Brent Smith
  • Publication number: 20050214168
    Abstract: Aerosol particle analyzer (APA) for measuring an analyte in airborne particle is described. Airborne particles are first given an electrical charge and then drawn in air past an oppositely charged volume of an analysis liquid that exposed to the air at a small hole in a container, such as a capillary, that holds that analysis liquid. Electrostatic forces enhance the rate that the airborne particles collide with the small exposed volume of the analysis liquid in the hole. If the particles that collide with the analysis liquid contain the analyte, an optical property of the analysis liquid, such as the fluorescence, varies according to the amount of the analyte in the particles. This optical property is measured and the amount of analyte in the particles is determined from the measured optical property.
    Type: Application
    Filed: March 26, 2004
    Publication date: September 29, 2005
    Inventors: Horn-Bond Lin, Steven Hill
  • Publication number: 20050179893
    Abstract: Aerosol particle analyzer (APA) for measuring the amount of analyte in airborne particle is described. The APA uses an analysis liquid. When this analysis liquid is mixed with the particles, an optical property of the analysis liquid (CDAL) varies according to the amount of the analyte in the particles. A charged droplet of the analysis liquid is levitated. Airborne particles are drawn into the instrument and given a charge that is opposite that of the CDAL, and made to flow near the CDAL so that electrostatic forces greatly increase the probability that the CDAL and charged particles will combine. Then the CDAL is ejected into a horizontally oriented linear quadrupole that is in an airtight container, except for a small orifice to let the CDAL enter. The CDAL is levitated in a high humidity environment so that it evaporates slowly, so that there is time for the reaction between the analyte, if any, and the CDAL can take place, and so that the optical property, typically fluorescence, can be measured.
    Type: Application
    Filed: February 14, 2004
    Publication date: August 18, 2005
    Applicant: U.S. Army Research Laboratory
    Inventor: Steven Hill
  • Publication number: 20050088304
    Abstract: The present invention is a mobile method and system for automatically monitoring the location and use of tools using radio-frequency identification (“RFID”) tags. An RFID tag is secured to each tool with a unique numerical identifier. The RFID tag transmits its unique numerical identifier associated with each of the RFID tags using a RF signal, wherein the RF signal is transmitted at different intervals for each of the RFID tags. A receiver on a mobile platform reads the RF signals and determines the unique numerical identifier being transmitted. An information processor interconnected with the receiver analyzes the unique numerical identifier from a predetermined index, and the information processor determines whether any tools were not found on the index and automatically alerts a user when a tool is missing.
    Type: Application
    Filed: September 13, 2004
    Publication date: April 28, 2005
    Inventors: Tony Hines, Steven Hill, Dennis Lusk
  • Publication number: 20050051777
    Abstract: A light emitting assembly comprising a solid state device coupleable with a power supply constructed and arranged to power the solid state device to emit from the solid state device. A series of rare-earth doped silicon and/or silicon carbide nanocrystals that are either combined in a single layer or in individual layers that produce the required Red, Green, and Blue (RGB) emission to form a white light.
    Type: Application
    Filed: July 22, 2004
    Publication date: March 10, 2005
    Inventor: Steven Hill
  • Patent number: 6751413
    Abstract: Multiple signals are monitored, for example, by an instrument used for monitoring wavelength division multiplexing (WDM) transmission systems. For each monitored frequency channel, an active mask is initialized. The active mask includes an operating window defined by a minimum frequency, a maximum frequency, a minimum amplitude and a maximum amplitude. Each signal is monitored to determine when the signal strays outside the operating window. An alarm is generated when the signal strays outside the operating window.
    Type: Grant
    Filed: February 5, 2001
    Date of Patent: June 15, 2004
    Assignee: Agilent Technologies, Inc.
    Inventors: Gregory Steven Hill, Joerg Hilger
  • Publication number: 20030135880
    Abstract: This invention describes methods, transgenic plants and transgenic microorganisms for the biosynthesis of halogenated natural products, where the halogenation is substrate and regiospecific. In particular, this invention relates to the use of halogenated metabolites, produced by the method of the invention, for the protection of host organisms against pathogens, more particularly, to the protection of plants against phytopathogens. In this aspect, the invention provides transgenic plants with enhanced resistance to phytopathogens, and biocontrol organisms with enhanced biocontrol properties.
    Type: Application
    Filed: July 2, 2002
    Publication date: July 17, 2003
    Inventors: John Steffens, Chris Batie, Jon Marquiz Dietz, Jian Dong, Kim Puloma Kamdar, Dwight Steven Hill
  • Patent number: 6588638
    Abstract: A key container mountable to the body of a vehicle includes a body and a removable cover. The body has a forward flanged end and a storage portion that may be inserted through an opening defined in the vehicle body. The flanged end has at least one hole adapted to receive a fastener for mounting the flanged end to the outside surface of the vehicle. An internal chamber for storing keys or other items is defined in the storage portion, and the chamber can be accessed through an access opening defined in the flanged end. The removable cover covers the access opening and the fasteners when the cover is coupled to the flanged end. A locking mechanism is coupled to the cover for locking the cover to the body of the key container at any orientation about its central axis.
    Type: Grant
    Filed: February 1, 2001
    Date of Patent: July 8, 2003
    Assignee: GE Interlogix, Inc.
    Inventors: Jon Marc Luebeck, Jose I. Vega, Mathew Steven Hill
  • Publication number: 20030080662
    Abstract: A refrigerator cabinet includes a bottom mullion and a casing. One of said bottom mullion and said casing includes a retaining tongue and the other of said bottom mullion includes an engagement surface for being received in said tongue. A method for fabricating the cabinet includes attaching the bottom mullion to a casing shell by hand, inserting an inner liner into the casing shell, attaching a casing bottom panel to the bottom mullion by hand, and injecting a foam insulation medium between the casing and the inner liner.
    Type: Application
    Filed: October 25, 2001
    Publication date: May 1, 2003
    Inventors: Steven Hilles Taylor, Charles William Newton
  • Publication number: 20030068788
    Abstract: Disclosed is a family of P450 monooxygenases, each member of which regioselectively oxidizes avermectin to 4″-keto-avermectin. The P450 monooxgenases find use in methods and formulations for making emamectin from avermectin. Also disclosed are methods for purifying the P450 monooxygenases of the invention, binding agents that specifically bind to the P450 monooxygenases of the invention, and genetically engineered cells that express the P450 monooxygenases of the invention. Also disclosed are ferredoxins and ferredoxin reductases that are active with the P450 monooxygenases of the invention.
    Type: Application
    Filed: May 14, 2002
    Publication date: April 10, 2003
    Inventors: Thomas Gunther Buckel, Philip Eugene Hammer, Dwight Steven Hill, James Madison Ligon, Istvan Molnar Durham, Johannes Paul Pachlatko, Ross Eric Zirkle
  • Publication number: 20020135834
    Abstract: Multiple signals are monitored, for example, by an instrument used for monitoring wavelength division multiplexing (WDM) transmission systems. For each monitored frequency channel, an active mask is initialized. The active mask includes an operating window defined by a minimum frequency, a maximum frequency, a minimum amplitude and a maximum amplitude. Each signal is monitored to determine when the signal strays outside the operating window. An alarm is generated when the signal strays outside the operating window.
    Type: Application
    Filed: February 5, 2001
    Publication date: September 26, 2002
    Inventors: Gregory Steven Hill, Joerg Hilger
  • Patent number: 6117670
    Abstract: The present invention is directed to the production of pyrrolnitrin in a host via recombinant expression of the polypeptides needed to biologically synthesize pyrrolnitrin. Genes isolated from P. fluorescens, P. pyrrocinia, B. cepacia, and M. fulvus that encode polypeptides necessary to produce pyrrolnitrin are provided, along with methods for identifying and isolating genes needed to recombinantly biosynthesize pyrrolnitrin from any organism capable of producing pyrrolnitrin. The isolated genes may be transformed and expressed in a desired host organisms to produce pyrrolnitrin according to the invention for a variety of purposes, including protecting the host from a pathogen, developing the host as a biocontrol agent, and producing large, uniform amounts of pyrrolnitrin.
    Type: Grant
    Filed: February 24, 1998
    Date of Patent: September 12, 2000
    Assignee: Novartis Finance Corporation
    Inventors: James Madison Ligon, Dwight Steven Hill, Stephen Ting Lam, Philip Eugene Hammer, Karl-Heinz van Pee, Sabine Kirner, Thomas R. Young
  • Patent number: 5955348
    Abstract: Strains of Pseudomonas have been genetically engineered to have enhanced biocontrol properties. The strains of the invention are particularly effective against plant pathogenic fungi such as species of Rhizoctonia and Pythium, because the strains produce enhanced amounts of antifungal metabolites such as pyrrolnitrin that are active against these fungal pathogens. Both the genetically modified biocontrol strains and the antifungal metabolites can be used as active agents for biocontrol compositions.
    Type: Grant
    Filed: November 25, 1997
    Date of Patent: September 21, 1999
    Assignee: Novartis AG
    Inventors: James Madison Ligon, Nancy R. Torkewitz, Dwight Steven Hill, Thomas Deane Gaffney, Jill Michelle Stafford
  • Patent number: 5817502
    Abstract: The present invention is directed to the production of an antipathogenic substance (APS) in a host via recombinant expression of the polypeptides needed to biologically synthesize the APS. Genes encoding polypeptides necessary to produce particular antipathogenic substances are provided, along with methods for identifying and isolating genes needed to recombinantly biosynthesize any desired APS. The cloned genes may be transformed and expressed in a desired host organisms to produce the APS according to the invention for a variety of purposes, including protecting the host from a pathogen, developing the host as a biocontrol agent, and producing large, uniform amounts of the APS.
    Type: Grant
    Filed: October 9, 1996
    Date of Patent: October 6, 1998
    Assignee: Novartis Finance Corporation
    Inventors: James M. Ligon, Dwight Steven Hill, Stephen Ting Lam, Philip E. Hammer, Karl-Heinz van Pee, Sabine Kirner
  • Patent number: 5737519
    Abstract: Apparatus and method for the early detection of faults in a head-disc assembly (HDA) from a disc drive manufacturing process. Parametrics are obtained from an HDA at a parametric station and provided to a pattern recognition system for estimating an error rate category from the measured HDA parametrics. The estimated error rate category and the parametrics are provided to a fuzzy inferencing system, which uses linguistic rules to classify the HDA as GOOD, MARGINAL or BAD, based upon the parametrics and the estimated error rate category. HDAs classified as GOOD or MARGINAL continue processing through dynamic burn-in (DBI), while HDAs classified as BAD are subjected to rework. The pattern recognition system includes a reference database containing historical parametric and associated error rate data, which is updated over time by the subsequent inclusion of selected parametrics and measured error rates for HDAs subjected to DBI.
    Type: Grant
    Filed: August 22, 1995
    Date of Patent: April 7, 1998
    Assignee: Seagate Technology, Inc.
    Inventors: Ghassan Maurice Abdelnour, Steven Hill Rogers, Horace David Chandler
  • Patent number: 5723759
    Abstract: The present invention is directed to the production of an antipathogenic substance (APS) in a host via recombinant expression of the polypeptides needed to biologically synthesize the APS. Genes encoding polypeptides necessary to produce particular antipathogenic substances are provided, along with methods for identifying and isolating genes needed to recombinantly biosynthesize any desired APS. The cloned genes may be transformed and expressed in a desired host organisms to produce the APS according to the invention for a variety of purposes, including protecting the host from a pathogen, developing the host as a biocontrol agent, and producing large, uniform amounts of the APS.
    Type: Grant
    Filed: June 1, 1995
    Date of Patent: March 3, 1998
    Assignee: Novartis Finance Corporation
    Inventors: James M. Ligon, Dwight Steven Hill, John Andrew Ryals, Stephen Ting Lam, Philip E. Hammer
  • Patent number: 5710031
    Abstract: Gene activating sequences which activate the expression of other bacterial genes, which are latent or expressed at low levels, are provided. The gene activating sequences confer the ability to produce several metabolites and may be transferred to bacterial strains. The transformed biocontrol agents are active to inhibit the growth of the fungal pathogens.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: January 20, 1998
    Assignee: Novartis Finance Corporation
    Inventors: Thomas D. Gaffney, Stephen T. Lam, James M. Ligon, Dwight Steven Hill, Jeffrey I. Stein
  • Patent number: 5698425
    Abstract: The present invention is directed to the production of an antipathogenic substance (APS) in a host via recombinant expression of the polypeptides needed to biologically synthesize the APS. Genes encoding polypeptides necessary to produce particular antipathogenic substances are provided, along with methods for identifying and isolating genes needed to recombinantly biosynthesize any desired APS. The cloned genes may be transformed and expressed in a desired host organisms to produce the APS according to the invention for a variety of purposes, including protecting the host from a pathogen, developing the host as a biocontrol agent, and producing large, uniform amounts of the APS.
    Type: Grant
    Filed: June 1, 1995
    Date of Patent: December 16, 1997
    Assignee: Novartis Finance Corporation
    Inventors: James M. Ligon, Thomas Schupp, James Joseph Beck, Dwight Steven Hill, John Andrew Ryals, Stephen Ting Lam, Philip E. Hammer, Scott Joseph Uknes
  • Patent number: 5679560
    Abstract: The present invention is directed to the production of an antipathogenic substance (APS) in a host via recombinant expression of the polypeptides needed to biologically synthesize the APS. Genes encoding polypeptides necessary to produce particular antipathogenic substances are provided, along with methods for identifying and isolating genes needed to recombinantly biosynthesize any desired APS. The cloned genes may be transformed and expressed in a desired host organisms to produce the APS according to the invention for a variety of purposes, including protecting the host from a pathogen, developing the host as a biocontrol agent, and producing large, uniform amounts of the APS.
    Type: Grant
    Filed: June 1, 1995
    Date of Patent: October 21, 1997
    Assignee: Novartis Finance Corporation
    Inventors: James M. Ligon, Dwight Steven Hill, Stephen Ting Lam, Philip E. Hammer
  • Patent number: 5670350
    Abstract: Gene activating sequences which activate the expression of other bacterial genes, which are latent or expressed at low levels, are provided. The gene activating sequences confer the ability to produce several metabolites and may be transferred to bacterial strains. The transformed biocontrol agents are active to inhibit the growth of the fungal pathogens.
    Type: Grant
    Filed: August 8, 1994
    Date of Patent: September 23, 1997
    Assignee: Novartis Finance Corporation
    Inventors: Thomas D. Gaffney, Stephen T. Lam, Dwight Steven Hill, Jeffrey I. Stein, James M. Ligon